Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril vs Lisinopril in Resistant Hypertension
NCT02623036Phase 1Unknown
- Sponsor
- Memorial Health University Medical Center
- Start
- Nov 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of enalapril in resistant hypertension (RH) (2 arms), sponsored by Memorial Health University Medical Center. Primary endpoint: Change from baseline nighttime blood pressure. Status: unknown.
02
Drugs
enalapril
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02623036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623036.